In a study on mouse TNBC model, T effectors and tumor cells compete for glutamine from the microenvironment; deletion of glutaminase in tumor cells, an enzyme crucial for glutamine metabolism, activates T cells and enhances antitumor immune responses[103]. Here, GLS is linked to neoplasm.